Comparative effects of sulphonylureas, dipeptidyl peptidase‐4 inhibitors and sodium‐glucose co‐transporter‐2 inhibitors added to metformin monotherapy: a propensity‐score matched cohort study in UK primary care

AIM: To assess the comparative effects of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors, sulphonylureas (SUs) and dipeptidyl peptidase‐4 (DPP‐4) inhibitors on cardiometabolic risk factors in routine care. MATERIALS AND METHODS: Using primary care data on 10 631 new users of SUs, SGLT2 inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkinson, Samantha, Williamson, Elizabeth, Pokrajac, Ana, Fogarty, Damian, Stirnadel‐Farrant, Heide, Smeeth, Liam, Douglas, Ian J., Tomlinson, Laurie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187358/
https://www.ncbi.nlm.nih.gov/pubmed/31957254
http://dx.doi.org/10.1111/dom.13970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187358/
https://www.ncbi.nlm.nih.gov/pubmed/31957254
http://dx.doi.org/10.1111/dom.13970

Ejemplares similares